|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,445.00 TWD | +3.58% |
|
+25.11% | +207.45% |
| 18/06 | PharmaEssentia Rebuffs Media Report Speculating Profit, Revenue for 2026 | MT |
| 11/06 | PharmaEssentia Completes Enrollment for Phase III Primary Myelofibrosis Drug Study | MT |
| Market Cap | 54TCr 1.68TCr 1.46TCr 1.35TCr 1.25TCr 2.38TCr 1,59900Cr 2.41TCr 16TCr 6.27TCr 78TCr 6.29TCr 6.16TCr 2,71700Cr | P/E 2026 * |
50x | P/E 2027 * | 36.4x |
|---|---|---|---|---|---|
| Enterprise Value | 51TCr 1.59TCr 1.39TCr 1.28TCr 1.19TCr 2.26TCr 1,52000Cr 2.29TCr 15TCr 5.96TCr 75TCr 5.98TCr 5.85TCr 2,58300Cr | EV / Sales 2026 * |
20.4x | EV / Sales 2027 * | 14.5x |
| Free-Float |
78.15% | Yield 2026 * |
0.06% | Yield 2027 * | 0.08% |
| 1 day | +3.58% | ||
| 1 week | +25.11% | ||
| Current month | +7.84% | ||
| 1 month | +54.22% | ||
| 3 months | +128.64% | ||
| 6 months | +194.60% | ||
| Current year | +207.45% |
| 1 week | 1,285 |  | 1,470 |
| 1 month | 907 | | 1,470 |
| Current year | 470 | | 1,470 |
| 1 year | 438.85 | | 1,470 |
| 3 years | 246.91 | | 1,470 |
| 5 years | 62.18 | | 1,470 |
| 10 years | 48.3 | | 1,470 |
| Manager | Title | Age | Since |
|---|---|---|---|
Kuo Chung Lin
CEO | Chief Executive Officer | - | 01/01/2003 |
Hsueh Ling Chang
DFI | Director of Finance/CFO | - | 14/10/2015 |
Albert Qin
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Ching Liu Chan
CHM | Chairman | - | 01/09/2003 |
Cheng Ku Huang
BRD | Director/Board Member | - | - |
Chao Ho Chen
BRD | Director/Board Member | - | 30/06/2009 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.58% | +25.11% | +196.41% | +363.46% | 1.62TCr | |
| -2.14% | +3.65% | +74.05% | +131.89% | 5.91TCr | |
| -0.93% | +4.05% | +73.64% | +90.53% | 5.52TCr | |
| -3.71% | +2.97% | -14.61% | -13.89% | 2.47TCr | |
| -0.05% | +7.89% | +14.05% | +440.15% | 2.42TCr | |
| +0.64% | +14.41% | +44.27% | -3.20% | 1.97TCr | |
| -2.19% | +7.37% | +40.74% | -30.67% | 1.76TCr | |
| +4.91% | +25.24% | +44.61% | - | 1.48TCr | |
| -0.57% | +1.39% | +20.33% | +191.65% | 1.4TCr | |
| +0.26% | +3.28% | +77.16% | +139.49% | 1.22TCr | |
| Average | -0.02% | +7.83% | +57.06% | +145.49% | 2.58TCr | |
| Weighted average by Cap. | -0.66% | +6.26% | +58.52% | +134.98% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.51TCr 78Cr 68Cr 63Cr 58Cr 111.1Cr 7.46TCr 112.64Cr 752.56Cr 292.69Cr 3.66TCr 293.79Cr 287.37Cr 13TCr | 3.46TCr 107.95Cr 94Cr 87Cr 80Cr 153.22Cr 10TCr 155.35Cr 1.04TCr 403.67Cr 5.05TCr 405.19Cr 396.33Cr 17TCr |
| Net income | 1.08TCr 34Cr 30Cr 27Cr 25Cr 48Cr 3.23TCr 49Cr 325.44Cr 126.57Cr 1.58TCr 127.05Cr 124.27Cr 5.48TCr | 1.5TCr 47Cr 41Cr 38Cr 35Cr 66Cr 4.45TCr 67Cr 449.06Cr 174.65Cr 2.18TCr 175.31Cr 171.48Cr 7.57TCr |
| Net Debt | -2.65TCr -83Cr -72Cr -67Cr -62Cr -117.58Cr -7.9TCr -119.21Cr -796.43Cr -309.76Cr -3.87TCr -310.92Cr -304.12Cr -13TCr | -3.47TCr -108.45Cr -95Cr -87Cr -81Cr -153.94Cr -10TCr -156.08Cr -1.04TCr -405.56Cr -5.07TCr -407.09Cr -398.19Cr -18TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/26/06 | NT$1,445.00 | +3.58% | 26,23,208 |
| 03/26/03 | NT$1,395.00 | 0.00% | 32,05,716 |
| 02/26/02 | NT$1,395.00 | +2.57% | 26,00,601 |
| 01/26/01 | NT$1,360.00 | +1.49% | 26,75,199 |
| 30/26/30 | NT$1,340.00 | +5.51% | 51,21,807 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 6446 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
